Stoxx Europe 50
5.047,28
PKT
-78,24
PKT
-1,53
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu Stoxx Europe 50-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 05.02.26 | BBVA Buy | UBS AG | |
| 05.02.26 | BNP Paribas Outperform | RBC Capital Markets | |
| 05.02.26 | Shell (ex Royal Dutch Shell) Sector Perform | RBC Capital Markets | |
| 05.02.26 | Santander Halten | DZ BANK | |
| 05.02.26 | UBS Kaufen | DZ BANK | |
| 05.02.26 | GSK Underweight | JP Morgan Chase & Co. | |
| 05.02.26 | BNP Paribas Overweight | JP Morgan Chase & Co. | |
| 05.02.26 | BBVA Overweight | JP Morgan Chase & Co. | |
| 05.02.26 | Rheinmetall Overweight | Barclays Capital | |
| 05.02.26 | Rheinmetall Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 05.02.26 | GSK Hold | Deutsche Bank AG | |
| 05.02.26 | UBS Buy | Deutsche Bank AG | |
| 05.02.26 | Novo Nordisk Buy | Deutsche Bank AG | |
| 05.02.26 | Novartis Buy | Deutsche Bank AG | |
| 05.02.26 | BAT Buy | Deutsche Bank AG | |
| 05.02.26 | BNP Paribas Hold | Deutsche Bank AG | |
| 05.02.26 | BBVA Sector Perform | RBC Capital Markets | |
| 05.02.26 | HSBC Neutral | JP Morgan Chase & Co. | |
| 05.02.26 | LOréal Buy | UBS AG | |
| 05.02.26 | Novo Nordisk Neutral | UBS AG | |
| 05.02.26 | Rheinmetall Overweight | JP Morgan Chase & Co. | |
| 05.02.26 | Rheinmetall Buy | Jefferies & Company Inc. | |
| 05.02.26 | BP Sector Perform | RBC Capital Markets | |
| 05.02.26 | Siemens Overweight | JP Morgan Chase & Co. | |
| 04.02.26 | SAP Buy | Goldman Sachs Group Inc. | |
| 04.02.26 | Intesa Sanpaolo Buy | Deutsche Bank AG | |
| 04.02.26 | SAP Buy | Deutsche Bank AG | |
| 04.02.26 | RELX Buy | Deutsche Bank AG | |
| 04.02.26 | Santander Buy | Deutsche Bank AG | |
| 04.02.26 | Intesa Sanpaolo Buy | UBS AG | |
| 04.02.26 | London Stock Exchange (LSE) Buy | UBS AG | |
| 04.02.26 | UBS Buy | Jefferies & Company Inc. | |
| 04.02.26 | UBS Outperform | RBC Capital Markets | |
| 04.02.26 | Santander Buy | Jefferies & Company Inc. | |
| 04.02.26 | Novartis Neutral | UBS AG | |
| 04.02.26 | GSK Buy | Jefferies & Company Inc. | |
| 04.02.26 | Santander Overweight | Barclays Capital | |
| 04.02.26 | Santander Sector Perform | RBC Capital Markets | |
| 04.02.26 | Novartis Sell | Goldman Sachs Group Inc. | |
| 04.02.26 | UBS Underweight | Barclays Capital |